Company profile: Devana Solutions
1.1 - Company Overview
Company description
- Provider of SaaS solutions that connect research sites with sponsors and CROs to reduce drug development costs through data transparency and selection of top-performing sites. PROPEL supports trial opportunity tracking and real-time collaboration; CENTRAL enables startup automation, pipeline and trial tracking, workflow automation, customizable dashboards; ENTERPRISE adds advanced collaboration, site capability queries, and comprehensive profiles.
Products and services
- ENTERPRISE: Advanced product enabling real-time collaboration, tracking trial opportunities, executing site capability queries, and constructing comprehensive site profiles for sponsors and CRO-aligned research networks
- CENTRAL: Customizable system that architects startup automation, pipeline management, trial tracking, workflow automation, and site management with configurable reports and dashboards for centralized oversight
- PROPEL: Real-time platform that tracks and monitors trial opportunities, manages contacts, and facilitates communication and collaboration between central research teams and decentralized staff
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Devana Solutions
Deep Genomics
HQ: Canada
Website
- Description: Provider of an AI platform that analyzes RNA biology, identifies novel targets, and evaluates therapeutic candidates; BigRNA, the first RNA foundation model for RNA therapeutics that discovers new biological mechanisms and RNA therapeutic candidates; and BigRNA+, which expands BigRNA to include more genetic mechanisms and diseases for broader therapeutic discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Genomics company profile →
Synthace
HQ: United Kingdom
Website
- Description: Provider of a SaaS digital experiment platform for life science R&D that digitizes experiments end-to-end, enabling scientists to design, simulate, run, and analyze reproducible experiments without code. Integrates data and metadata, supports dynamic automation for frequent updates, offers a drag-and-drop workflow builder translating human directions to robot instructions, and DOE tools for media optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synthace company profile →
IPM.ai
HQ: United States
Website
- Description: Provider of HIPAA-certified machine learning infrastructure for biopharma, delivering AI-powered patient finding, insights-as-a-service, and a system of insight using real-world data to optimize drug development and commercialization. Services include clinical study recruitment, market assessment, and patient journey mapping for specialty and rare diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IPM.ai company profile →
Automata
HQ: United Kingdom
Website
- Description: Provider of workflow and robotic automation for life sciences labs, helping them innovate, diagnose and discover at scale, enabling faster results and scalable operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Automata company profile →
ConcertAI
HQ: United States
Website
- Description: Provider of AI-powered SaaS medical research tools and integrated real-world data solutions for oncology. Offerings include AI-enriched datasets for clinical and outcomes research, regulatory-grade external control arms, pragmatic trials, post-approval studies, virtual EMR-claims registries, and regulatory research with custom real-world data abstraction and scientific consultation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ConcertAI company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Devana Solutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Devana Solutions
2.2 - Growth funds investing in similar companies to Devana Solutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Devana Solutions
4.2 - Public trading comparable groups for Devana Solutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →